Home / Inspections / 1064469

FDA Inspection 1064469 — Labcorp Drug Development

Labcorp Drug Development — FEI 2242945

The FDA completed an inspection of Labcorp Drug Development on July 19, 2018 in Princeton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 19, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1168630 (NAI Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1147393 (NAI Thu Jun 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1123056 (NAI Thu Mar 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1022660 (NAI Wed Jul 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 790402 (NAI Fri Jul 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources